The IPO Buzz: Seaport Therapeutics Increases IPO’s Size & Prices it at $18 – Top of Range
Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each
Seaport and Hemab target $180m IPOs as biotech listings accumulate
Trump’s Rogan-inspired psychedelics order stokes cautious optimism
Neuropsychiatric drug developer Seaport files for U.S. IPO
Neuropsychiatric therapeutics biotech Seaport Therapeutics files for a $100 million IPO